...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
AGORACOM NEWS FLASH

BREAKING: Spyder Cannabis Receives Approval on Development Permit for its Flagship Cannabis Store in Calgary, Alberta

  • Received approval on their development permit for a flagship retail location in the heart of Calgary
  • Spyder has now been accepted by Alberta Health Services and will begin construction in the coming weeks.
  • This brings Spyder’s total retail to 6 locations across Ontario and Alberta, this number is expected to grow over the coming months.

Spdr logo large

Hub On AGORACOM / Read Release

Message: Impact factors

First, impact factors are NOT a quality metric, they are simply a measure of citation frequencyl. 

Scond, before anyone has had some Fear, Uncertainty or Doubt about the quality of the research by RVX, the RVX208-publication in Atherosclerosis received the following analysis - where the Atherosclerosis paper is said to be extremely highly cited (=high impact as per the impact factor definition).

https://badge.dimensions.ai/details/id/pub.1020671341

"This publication in Atherosclerosis has been cited 36 times. 94% of its citations have been received in the past two years, which is higher than you might expect, suggesting that it is currently receiving a lot of interest.

Compared to other publications in the same field, this publication is extremely highly cited and has received approximately 12 times more citations than average."

 

Share
New Message
Please login to post a reply